NovaVision has announced the benefits of its clinically supported, light-stimulation-based vision restoration therapy (VRT), designed to diagnose and improve visual function in patients who have suffered a stroke or traumatic brain injury.
The study of VRT, a non-invasive therapy, indicated that it was easy to use and improved patients’ visual function.
NovaVision sales and marketing vice-president Tom Bridges said that VRT was an approach to rewire visual nerves, with the aim of getting healthy neurons to perform the function of those damaged or destroyed by a stroke.
There are more than six million stroke survivors living in America, of whom about 20% suffer from visual field loss.
Related
Visual field deficits include hemianopia, scotoma, quadrantoanopia and constriction.
Related Companies
